San Francisco--Although laparoscopic partial nephrectomy techniques have come a long way, there is still much progress needed before the procedure can be easily performed by surgeons, Cleveland Clinic researchers said.
Study identifies 11 gene mutations linked to aggressive prostate cancer
October 3rd 2023This is the largest prostate cancer study that examined the exome, according to the researchers, who believe their findings can potentially inform the makeup of panels used for genetic testing in prostate cancer.
Dr. Schuster highlights the FDA approval of imaging agent flotufolastat F 18 in prostate cancer
June 22nd 2023"We're excited that the FDA approval of this radiotracer gives us yet more tools at our disposal to diagnose prostate cancer in all its forms, from early to late in the disease process," says David M. Schuster, MD, FACR.
2 Clarke Drive
Cranbury, NJ 08512